Yinghui Wei

716 total citations
26 papers, 583 citations indexed

About

Yinghui Wei is a scholar working on Molecular Biology, Biomedical Engineering and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yinghui Wei has authored 26 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Biomedical Engineering and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yinghui Wei's work include Nanoplatforms for cancer theranostics (6 papers), Retinoids in leukemia and cellular processes (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Yinghui Wei is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), Retinoids in leukemia and cellular processes (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Yinghui Wei collaborates with scholars based in China, United Kingdom and Denmark. Yinghui Wei's co-authors include Fanzhu Li, Shunping Han, Hangsheng Zheng, Manman Guo, Xiaoli Ye, Xiaoguang Shang, Jingwen Luo, Weidong Fei, Xuan Peng and Hongyue Zheng and has published in prestigious journals such as Biomaterials, Chemical Engineering Journal and Acta Biomaterialia.

In The Last Decade

Yinghui Wei

23 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yinghui Wei China 14 200 148 123 123 64 26 583
Nagarjun Rangaraj India 14 152 0.8× 245 1.7× 141 1.1× 78 0.6× 49 0.8× 18 599
Sunitha Sampathi India 16 190 0.9× 315 2.1× 193 1.6× 109 0.9× 62 1.0× 37 734
Muhammad Sarfraz Pakistan 11 224 1.1× 76 0.5× 121 1.0× 113 0.9× 36 0.6× 30 594
Ravinder Verma India 14 207 1.0× 212 1.4× 209 1.7× 166 1.3× 131 2.0× 61 835
Chien‐Ming Hsieh Taiwan 16 185 0.9× 96 0.6× 125 1.0× 120 1.0× 37 0.6× 38 583
Cuiyan Han China 16 273 1.4× 105 0.7× 284 2.3× 194 1.6× 109 1.7× 42 734
Dongqin Quan China 16 211 1.1× 160 1.1× 108 0.9× 107 0.9× 66 1.0× 36 600
Venkateshwaran Krishnaswami India 15 173 0.9× 125 0.8× 142 1.2× 137 1.1× 63 1.0× 46 591
Haiying Hua China 13 238 1.2× 87 0.6× 104 0.8× 74 0.6× 30 0.5× 44 574

Countries citing papers authored by Yinghui Wei

Since Specialization
Citations

This map shows the geographic impact of Yinghui Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinghui Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinghui Wei more than expected).

Fields of papers citing papers by Yinghui Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinghui Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinghui Wei. The network helps show where Yinghui Wei may publish in the future.

Co-authorship network of co-authors of Yinghui Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Yinghui Wei. A scholar is included among the top collaborators of Yinghui Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinghui Wei. Yinghui Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, He, Jianjun Lai, Yajun Wu, et al.. (2025). Arsenene-Vanadene nanodots co-activate Apoptosis/Ferroptosis for enhanced chemo-immunotherapy. Acta Biomaterialia. 196. 453–470.
3.
Hou, Yu, Lin Zhu, Qibin Zhang, et al.. (2022). Deoxycholic acid-chitosan coated liposomes combined with in situ colonic gel enhances renal fibrosis therapy of emodin. Phytomedicine. 101. 154110–154110. 20 indexed citations
4.
Bao, Dandan, Xiaowei Xie, Ke Zhang, et al.. (2022). Hydroxy-safflower yellow A composites: An effective strategy to enhance anti-myocardial ischemia by improving intestinal permeability. International Journal of Pharmaceutics. 623. 121918–121918. 6 indexed citations
5.
Hou, Yu, Xudong Fan, Hangsheng Zheng, et al.. (2022). Hierarchically structured microcapsules for oral delivery of emodin and tanshinone IIA to treat renal fibrosis. International Journal of Pharmaceutics. 616. 121490–121490. 15 indexed citations
6.
Fan, Yuhang, Yujie Lu, Wei Yan, et al.. (2022). Correlation between in vivo microdialysis pharmacokinetics and ex vivo permeation for sinomenine hydrochloride transfersomes with enhanced skin absorption. International Journal of Pharmaceutics. 621. 121789–121789. 13 indexed citations
8.
Luo, Jingwen, et al.. (2021). Deoxycholic acid-functionalised nanoparticles for oral delivery of rhein. European Journal of Pharmaceutical Sciences. 159. 105713–105713. 35 indexed citations
9.
Li, Chaoqun, Ke Zhang, Yinghui Wei, et al.. (2021). MMP2-responsive dual-targeting drug delivery system for valence-controlled arsenic trioxide prodrug delivery against hepatic carcinoma. International Journal of Pharmaceutics. 609. 121209–121209. 15 indexed citations
10.
Zheng, Hangsheng, Juan Wang, Mingshi Yang, et al.. (2020). Monoterpenes-containing PEGylated transfersomes for enhancing joint cavity drug delivery evidenced by CLSM and double-sited microdialysis. Materials Science and Engineering C. 113. 110929–110929. 20 indexed citations
11.
Luo, Xiaoting, et al.. (2020). Codelivery of Emodin and Diammonium Glycyrrhizinate by Anti-alpha8 Integrin-Conjugated Immunoliposomes for the Treatment of Renal Fibrosis. Journal of Nanomaterials. 2020. 1–15. 2 indexed citations
12.
Chen, Danfei, et al.. (2018). Kidney-targeted drug delivery via rhein-loaded polyethyleneglycol-<em>co</em>-polycaprolactone-<em>co</em>-polyethyleneimine nanoparticles for diabetic nephropathy therapy. International Journal of Nanomedicine. Volume 13. 3507–3527. 47 indexed citations
13.
Luo, Jingwen, et al.. (2018). Low molecular weight chitosan-based conjugates for efficient Rhein oral delivery: synthesis, characterization, and pharmacokinetics. Drug Development and Industrial Pharmacy. 45(1). 96–104. 21 indexed citations
14.
Fei, Weidong, Yan Zhang, Shunping Han, et al.. (2017). RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma. International Journal of Pharmaceutics. 519(1-2). 250–262. 71 indexed citations
15.
Wei, Yinghui, et al.. (2017). Biodegradable nanoparticles for improved kidney bioavailability of rhein: preparation, characterization, plasma, and kidney pharmacokinetics. Drug Development and Industrial Pharmacy. 43(11). 1885–1891. 19 indexed citations
16.
Mu, Chaofeng, Jianliang Shen, Jing Liang, et al.. (2017). Targeted drug delivery for tumor therapy inside the bone marrow. Biomaterials. 155. 191–202. 65 indexed citations
17.
Wei, Yinghui, et al.. (2015). Effect of glycyrrhizic acid on rhein renal penetration: a microdialysis study in rats. Xenobiotica. 45(12). 1116–1121. 2 indexed citations
18.
Liu, Hongzhuo, Jinling Tang, Yinghui Wei, et al.. (2015). Enhanced bioavailability of nerve growth factor with phytantriol lipid-based crystalline nanoparticles in cochlea. International Journal of Nanomedicine. 10. 6879–6879. 29 indexed citations
19.
Wei, Yinghui. (2013). Analysis of the Construction of Harmonious Graduate Teacher-Student Relationship. Journal of Shenyang Jianzhu University. 1 indexed citations
20.
Wei, Yinghui, Xiaoli Ye, Xiaoguang Shang, et al.. (2011). Enhanced oral bioavailability of silybin by a supersaturatable self-emulsifying drug delivery system (S-SEDDS). Colloids and Surfaces A Physicochemical and Engineering Aspects. 396. 22–28. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026